Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-03 Sale | 2024-06-05 9:30 pm | Evolus Inc. | EOLS | Malik Vikram Director | 7,500 | $12.96 | $97,203 | 246,514 (Direct) | View |
2024-05-13 Sale | 2024-05-15 5:19 pm | Evolus Inc. | EOLS | Malik Vikram Director | 28,000 | $12.93 | $362,012 | 254,014 (Direct) | View |
2023-08-15 Purchase | 2023-08-15 4:34 pm | Evolus Inc. | EOLS | Malik Vikram Director | 174,967 | $7.41 | $1,296,505 | 298,548 (Direct) | View |
2021-08-23 Sale | 2021-08-25 6:37 pm | Evolus Inc. | EOLS | Malik Vikram Director | 26,077 | $11 | $286,722 | 1,143,701 (Indirect) | View |
2021-08-19 Sale | 2021-08-20 8:19 pm | Evolus Inc. | EOLS | Malik Vikram Director | 61,840 | $10.59 | $654,871 | 1,169,778 (Indirect) | View |
2021-08-17 Sale | 2021-08-19 7:01 pm | Evolus Inc. | EOLS | Malik Vikram Director | 67,083 | $10.2 | $684,561 | 1,231,618 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-07 Option Award | 2024-02-09 6:37 pm | N/A 2034-02-07 | Evolus Inc. | EOLS | Malik Vikram Director | 15,841 | $0 | 291,391 (Direct) | View |
2023-08-11 Other | 2023-08-15 4:34 pm | N/A N/A | Evolus Inc. | EOLS | Malik Vikram Director | 22,998 | $0 | 298,548 (Direct) | View |
2023-07-21 Conversion | 2023-07-26 5:06 pm | N/A N/A | AEON Biopharma Inc. | AEON | Priveterra Sponsor LLC Grodnensky Oleg PALMISANO ROBERT J Malik Vikram 10% Owner | 7,215,001 | $0 | 14,115,001 (Direct) | View |
2023-07-21 Option Award | 2023-07-26 5:06 pm | N/A N/A | AEON Biopharma Inc. | AEON | Priveterra Sponsor LLC Grodnensky Oleg PALMISANO ROBERT J Malik Vikram 10% Owner | 5,280,000 | $0 | 14,115,001 (Direct) | View |
2023-01-27 Option Award | 2023-01-31 8:42 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | Malik Vikram Director | 20,082 | $0 | 89,374 (Direct) | View |
2022-01-24 Option Award | 2022-01-26 9:02 pm | N/A 2032-01-24 | Evolus Inc. | EOLS | Malik Vikram Director | 38,295 | $0 | 92,019 (Direct) | View |
2021-03-26 Option Award | 2021-03-26 7:05 pm | N/A N/A | Evolus Inc. | EOLS | Malik Vikram Director | 18,011 | $0 | 53,724 (Direct) | View |
2021-02-05 Option Award | 2021-02-09 5:13 pm | N/A N/A | Evolus Inc. | EOLS | Malik Vikram Director | 19,313 | $0 | 35,713 (Direct) | View |
Ownership | 2021-02-08 9:57 pm | N/A N/A | Priveterra Acquisition Corp. | PMGM | Priveterra Sponsor LLC PALMISANO ROBERT J Malik Vikram Grodnensky Oleg Director 10% Owner | 0 | $0 | 6,900,000 (Direct) | View |
2020-01-23 Option Award | 2020-01-24 9:07 pm | N/A 2030-01-23 | Evolus Inc. | EOLS | Malik Vikram Director | 23,458 | $0 | 23,458 (Direct) | View |